Test Price
2,800 AED✅ Home Collection Available
CYP4V2 Gene Analysis for Bietti Crystalline Corneoretinal Dystrophy (Genetic Test) in UAE | 2800 AED | DHA-Licensed
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM – 11 PM.
Clinical Guidance: Post-test telephonic consultation with a certified genetic counselor for result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CYP4V2 gene analysis uses Next‑Generation Sequencing (NGS) to detect pathogenic variants associated with Bietti crystalline corneoretinal dystrophy, a rare inherited eye disorder. This test provides definitive molecular confirmation for patients with suggestive retinal crystals and chorioretinal atrophy, guiding family screening and reproductive planning. Full‑gene sequencing covers all coding exons and splice sites, with sensitive copy number variant detection.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing Single Exon) |
|---|---|---|
| Methodology | Full‑gene NGS with copy number variant detection | Targeted sequencing of one or two exons |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Regulatory Compliance | ISO 9001:2015 · MOHAP/DHA Licensed | Varies by provider |
| Home Collection | 8 AM – 11 PM Cold‑Chain, VIP Phlebotomy | Limited availability |
Physician Insight & Safety Protocols
“Bietti crystalline dystrophy is a progressive condition with variable age of onset. Genetic testing confirms the molecular diagnosis, but the results must always be correlated with the complete clinical picture by an experienced clinical geneticist. This test empowers families with clarity and helps in planning for future eye health and reproductive options.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory & Safety Information
Important Medication Advisory
Do not discontinue any prescribed medication or eye treatment without consulting your doctor. This genetic test does not replace regular ophthalmic follow‑up. Always retain ongoing care with your ophthalmologist.
Exclusion Criteria & Safety Red Flags
- This test requires only a blood sample or FTA card; no invasive eye examination is needed.
- Minors (<18 years) must have consent from a legal guardian per UAE Federal Law.
- If you experience sudden vision loss, severe eye pain, or flashes/floaters, seek emergency ophthalmology care immediately – do not wait for genetic test results.
Patient FAQ & Clinical Guidance
1. What is the CYP4V2 gene test for Bietti crystalline dystrophy?
Snippet: This NGS test examines the entire CYP4V2 gene to identify disease‑causing mutations that confirm a clinical diagnosis of Bietti crystalline corneoretinal dystrophy.
2. How is the test performed and what does it cost in UAE?
Snippet: A small blood sample (or a finger‑prick drop on an FTA card) is collected at home by a certified phlebotomist; the total price is 2800 AED including cold‑chain logistics.
3. What do the results mean and what are the next steps?
Snippet: A positive report confirms the genetic cause of the disease; you will receive a genetic counselling session to discuss inheritance risk and family screening.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This test is performed under DHA Facility License No. 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. All data processing adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. The laboratory is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | CYP4V2 Gene Analysis for Bietti Crystalline Corneoretinal Dystrophy (Genetic Test) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or FTA card; VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM |
| Methodology Used | Next‑Generation Sequencing (NGS) – full gene with CNV detection |
| ICD-10-CM Code | H35.53 |
| LOINC Code | 21663-8 |
| DHA Facility License & Address | DHA License No. 1143 · Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE · DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians